XIGIFY

Serial Number 77535653
606

Registration Progress

Application Filed
Jul 31, 2008
Under Examination
Mar 10, 2009
Approved for Publication
Nov 26, 2008
Published for Opposition
Dec 16, 2008
Registered

Trademark Image

XIGIFY

Basic Information

Serial Number
77535653
Filing Date
July 31, 2008
Published for Opposition
December 16, 2008
Abandonment Date
April 12, 2010
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 12, 2010
Classes
005

Rights Holder

Pfizer Inc.

03
Address
235 East 42nd Street
New York, NY 10017

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Cindy Zelson

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

13 events
Date Code Type Description Documents
Apr 12, 2010 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 12, 2010 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Aug 25, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 25, 2009 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 25, 2009 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 10, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 16, 2008 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 26, 2008 NPUB O NOTICE OF PUBLICATION Loading...
Nov 10, 2008 ALIE A ASSIGNED TO LIE Loading...
Nov 10, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 4, 2008 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 30, 2008 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 4, 2008 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005